B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+0.15%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.03B
AUM Growth
+$3.03B
(+1.6%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-0.36%
Top 10 Holdings %
Top 10 Hldgs %
36.47%
Holding
102
New
13
Increased
18
Reduced
21
Closed
19
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$77.6M |
| 2 |
Harrow
HROW
|
$30.7M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$28.8M |
| 4 |
Day One Biopharmaceuticals
DAWN
|
$25.6M |
| 5 |
Terns Pharmaceuticals
TERN
|
$23.6M |
Top Sells
| 1 |
Natera
NTRA
|
$35.5M |
| 2 |
Travere Therapeutics
TVTX
|
$30.6M |
| 3 |
QuidelOrtho
QDEL
|
$25.7M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$23.8M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$23.3M |
Sector Composition
| 1 | Healthcare | 54.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
iTeos Therapeutics
ITOS
$449M
| – | – | -71,585 | Closed | -$1.4M |
|